Momentum Clinical Research is thrilled to announce the launch of the first and largest integrated network of clinical trial sites across Australia and New Zealand. This new powerhouse in clinical research brings together New Zealand’s respected P3 Research Ltd with Australia’s AusTrials and Holdsworth House, creating a unified entity with world-class sites that have been conducting groundbreaking research for more than 20 years.

The collaboration among these three distinguished brands marks a transformative moment in the clinical trial landscape, offering unprecedented access and convenience for sponsors and CROs looking to conduct Phase Ib to IV clinical trials across both countries. With a streamlined, centralised system, Momentum offers a single point of contact linking sponsors to 14 state-of-the-art sites across Australia and New Zealand, paving the way for rapid feasibility responses, accelerated study start-ups, and highly efficient recruitment processes.

Streamlined Access for Sponsors and CROs

For trial sponsors and CROs, Momentum represents a new level of opportunity and efficiency. With a network that spans both nations, Momentum is equipped to deliver fast, reliable recruitment and engagement across diverse patient populations, with the ability to meet the needs of each specific trial. The collaborative framework across 13 sites enables Momentum to significantly cut down on start-up times, allowing trials to begin quickly and proceed smoothly, all while maintaining the highest quality standards.

Access to an Extensive Participant Database

One of the standout benefits of partnering with Momentum is the access to a robust and diverse database of over 50,000 potential participants. This comprehensive database, combined with a proactive in-house recruitment team, ensures that studies are always well-supported with targeted, engaged participants who are prepared to contribute to each study’s unique requirements. This proactive approach to recruitment, rather than waiting until trials are awarded, allows Momentum to remain ready to meet the demands of any trial with precision and speed.

Enhancing the Clinical Trial Landscape

With a commitment to setting a new standard for clinical trials in Australia and New Zealand, Momentum Clinical Research is not just facilitating trials—it’s reshaping the clinical research landscape. By bringing together the expertise and resources of P3 Research, AusTrials, and Holdsworth House, Momentum combines a deep foundation of knowledge with a forward-thinking approach that prioritises efficiency, quality, and participant experience.

A Bright Future for Clinical Research

As clinical trials grow more complex, the need for cohesive, comprehensive networks like Momentum Clinical Research is more pressing than ever. The formation of this extensive network reflects a clear vision for the future of clinical research, one that prioritises collaboration, speed, and accessibility. For sponsors, CROs, and participants alike, Momentum Clinical Research promises a seamless, supportive experience that ensures trials are conducted with excellence and integrity.

Momentum is ready to take clinical research in Australia and New Zealand to new heights, providing an exceptional platform for conducting high-quality trials across a wide array of therapeutic areas. To learn more about Momentum Clinical Research and the benefits of partnering with the largest clinical trial network in the region contact our team today.